₹ 0.2 Cr
Volume Transacted
(Nov 21, 2024)
0.7 K
Stocks Traded
(Nov 21, 2024)
Last Updated on: Nov 22, 2024
Dr Lal Pathlabs Ltd
NSE: LALPATHLAB
EPS
₹ 48.03
Last updated on: Nov 21, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Dr Lal Pathlabs Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 25,309 Cr
EPS
₹ 48.0
P/E Ratio (TTM) *
63.0
P/B Ratio (TTM) *
12.6
Day’s High *
3049.75
Day’s Low
₹ 3012.0
DTE *
0.1
ROE *
20.1
52 Week High
₹ 3645.0
52 Week Low
₹ 1943.2
ROCE *
27.0
* All values are consolidated
Last Updated time: 22 Nov 9.00 AM
* All values are consolidated
Last Updated time: 22 Nov 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
21 Nov 2024 | 3028.25 | 3012 | 3049.75 | 3012 |
19 Nov 2024 | 3040.9 | 2919.55 | 3073.45 | 2919.55 |
18 Nov 2024 | 2968.2 | 2955.7 | 3011.55 | 2916.7 |
14 Nov 2024 | 2953.7 | 2950.05 | 2989.45 | 2929 |
13 Nov 2024 | 2964.25 | 3000 | 3020 | 2943.6 |
12 Nov 2024 | 3027.6 | 2970 | 3067 | 2970 |
11 Nov 2024 | 3011.1 | 3060.2 | 3078.7 | 2985.6 |
08 Nov 2024 | 3058.8 | 3061.65 | 3101.65 | 3047.05 |
07 Nov 2024 | 3071.1 | 3090.75 | 3121.75 | 3052.65 |
06 Nov 2024 | 3100.2 | 3082.15 | 3114.75 | 3077.3 |
Date | Price (₹) |
---|---|
21 Nov 2024 | 3028.25 |
19 Nov 2024 | 3040.9 |
18 Nov 2024 | 2968.2 |
14 Nov 2024 | 2953.7 |
13 Nov 2024 | 2964.25 |
12 Nov 2024 | 3027.6 |
11 Nov 2024 | 3011.1 |
08 Nov 2024 | 3058.8 |
07 Nov 2024 | 3071.1 |
06 Nov 2024 | 3100.2 |
Strength
6
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 25,310
Asset Value
₹ 1,058
22.9 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Dr Lal Pathlabs Ltd | 48 | 25,309 |
Apollo Hospitals Enterprise Ltd | 82 | 96,963 |
Max Healthcare Institute Ltd | 10 | 96,207 |
Fortis Healthcare Ltd | 9 | 51,379 |
Syngene International Ltd | 11 | 34,117 |
Global Health Ltd | 18 | 28,805 |
Historical Market Cap of Dr Lal Pathlabs Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Dr Lal Pathlabs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Dr Lal Pathlabs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Dr Lal Pathlabs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Dr. Lal PathLabs allots Equity shares
Dr. Lal PathLabs approved allotment of 5,000 Equity Shares under the ESOP 2010 Plan of the...
30 Oct 202411:47
Board of Dr. Lal PathLabs recommends Second Interim dividend
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...
23 Oct 202416:18
Dr. Lal PathLabs to declare Quarterly Result
Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 23 Octobe...
17 Oct 202415:53
Dr Lal Pathlabs allots 93,900 equity shares under ESOP
Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Op...
13 Aug 202409:10
Board of Dr. Lal PathLabs recommends interim dividend
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...
07 Aug 202416:35
Dr Lal PathLabs gains after Q1 PAT rises 29% YoY to Rs 108 cr
Revenue from operations increased 11.26% YoY to Rs 601.9 crore during the quarter. Profit ...
07 Aug 202415:36
Concalls
Unlimited trading at just
Rs. 199*